Are we at a stage to predict autoimmune rheumatic diseases?

[1]  T. Tuomi,et al.  Rheumatoid factors antedating clinical rheumatoid arthritis. , 1991, The Journal of rheumatology.

[2]  P. Lipsky,et al.  Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. , 2004, Arthritis and rheumatism.

[3]  Y. Shoenfeld,et al.  Predicting and Preventing Autoimmunity, Myth or Reality? , 2006, Annals of the New York Academy of Sciences.

[4]  M. Sticherling,et al.  Comparison of Different Test Systems for Simultaneous Autoantibody Detection in Connective Tissue Diseases , 2005, Annals of the New York Academy of Sciences.

[5]  William E. Earnshaw,et al.  Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. , 1991, Arthritis and rheumatism.

[6]  R. Liblau,et al.  Selective IgA deficiency and autoimmunity. , 1992, International archives of allergy and immunology.

[7]  F. Miller,et al.  Autoantibodies as Predictive and Diagnostic Markers of Idiopathic Inflammatory Myopathies , 2004, Autoimmunity.

[8]  R. Smeenk,et al.  Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). , 1985, Annals of the rheumatic diseases.

[9]  Y. Shoenfeld,et al.  Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity , 2006, Lupus.

[10]  J. French,et al.  The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.

[11]  Nicola Bizzaro,et al.  NOVEL DIAGNOSTIC METHODS FOR AUTOANTIBODY DETECTION , 2007 .

[12]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[13]  J. Mary,et al.  Value of laboratory tests in early prediction of rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[14]  Andrea Giordano,et al.  Autoantibodies Profile in the Sera of Patients with Sjogren]s Syndrome: The ANA Evaluation—A Homogeneous, Multiplexed System , 2004, Clinical & developmental immunology.

[15]  M J Fritzler,et al.  Advances and Applications of Multiplexed Diagnostic Technologies in Autoimmune Diseases , 2006, Lupus.

[16]  Mark C. Genovese,et al.  Computer-Assisted Pattern Recognition of Autoantibody Results , 2005, Clinical Diagnostic Laboratory Immunology.

[17]  Harry R. Hill,et al.  Evaluation of Multiplexed Fluorescent Microsphere Immunoassay for Detection of Autoantibodies to Nuclear Antigens , 2004, Clinical Diagnostic Laboratory Immunology.

[18]  M. Boscaro,et al.  II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  F. Breedveld,et al.  Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[20]  F. Breedveld,et al.  Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. , 2004, Arthritis and rheumatism.

[21]  F. Miller,et al.  The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. , 1996, Annals of the rheumatic diseases.

[23]  Y. Shoenfeld,et al.  The Homogeneous Multiplexed System-a New Method for Autoantibody Profile in Systemic Lupus Erythematosus , 2005, Clinical & developmental immunology.

[24]  G. Hallmans,et al.  A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis , 2004, Arthritis research & therapy.

[25]  V. Holers,et al.  Can we accurately predict the development of rheumatoid arthritis in the preclinical phase? , 2003, Arthritis and rheumatism.

[26]  E. Tan,et al.  Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .

[27]  J. Buyon,et al.  Autoantibody-Associated Congenital Heart Block: Outcome in Mothers and Children , 1994, Annals of Internal Medicine.

[28]  Bonnie Bruce,et al.  Antigen microarray profiling of autoantibodies in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[29]  Carole Foy,et al.  A comparability study of the emerging protein array platforms with established ELISA procedures. , 2005, Journal of immunological methods.

[30]  Koen Vos,et al.  How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. , 2002, Arthritis and rheumatism.

[31]  N. Bizzaro,et al.  Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. , 2001, Clinical chemistry.

[32]  S. West,et al.  Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. , 2005, Seminars in arthritis and rheumatism.

[33]  A. Wiik,et al.  Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIAr ANA Update for the detection of autoantibodies in connective tissue disorders , 2002, Clinical and experimental rheumatology.

[34]  Michel G Bergeron,et al.  Rapid molecular theranostics in infectious diseases. , 2002, Drug discovery today.

[35]  Srivatsa Venkatasubbarao,et al.  Microarrays--status and prospects. , 2004, Trends in biotechnology.

[36]  B. Dijkmans,et al.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.

[37]  M. Jolivet,et al.  Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non‐citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis , 2004, Clinical and experimental immunology.

[38]  Y. Shoenfeld,et al.  Prophylaxis of the antiphospholipid syndrome: a consensus report , 2003, Lupus.

[39]  D. Symmons,et al.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[40]  Dennis McGonagle,et al.  A Proposed Classification of the Immunological Diseases , 2006, PLoS medicine.

[41]  Amos Etzioni.  Immune deficiency and autoimmunity. , 2003, Autoimmunity reviews.

[42]  Y. Shoenfeld,et al.  Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases , 2005, Autoimmunity.

[43]  R Hal Scofield,et al.  Autoantibodies in Rheumatoid Arthritis Autoantibodies in Pregnancy Autoantibodies as Predictors of Disease , 2022 .

[44]  G. Ruiz-Irastorza,et al.  Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus , 2004, Lupus.

[45]  J. Buyon,et al.  Congenital complete heart block , 1990 .

[46]  P. Brown,et al.  Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.

[47]  P. Bennett,et al.  The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. , 1988, Arthritis and rheumatism.

[48]  G. Hu,et al.  Parallel detection of autoantibodies with microarrays in rheumatoid diseases. , 2004, Clinical chemistry.

[49]  Lawrence Steinman,et al.  Proteomics technologies for the study of autoimmune disease. , 2002, Arthritis and rheumatism.

[50]  H. Heinzl,et al.  Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis , 2005, Annals of the rheumatic diseases.

[51]  D Gianola,et al.  Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. , 1999, Clinical and experimental rheumatology.

[52]  W. Weston,et al.  Maternal and fetal outcome in neonatal lupus erythematosus. , 1987, Annals of internal medicine.

[53]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[54]  S R Binder,et al.  Autoantibody Detection Using Multiplex Technologies , 2006, Lupus.

[55]  J. Buyon.  Neonatal Lupus Syndromes , 1992, Current opinion in rheumatology.

[56]  Anne-Marie Rouquette,et al.  Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. , 2003, American journal of clinical pathology.

[57]  J. Alcocer-Varela,et al.  Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome , 2004, Lupus.

[58]  U. Wagner,et al.  HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[59]  J. Hazes,et al.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.

[60]  Göran Hallmans,et al.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[61]  I. Targoff,et al.  Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. , 1992, Arthritis and rheumatism.

[62]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[63]  P. Swarbrick,et al.  Determination of ANA Specificity Using the UltraPlex™ Platform , 2005, Annals of the New York Academy of Sciences.

[64]  A. Sette,et al.  Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule1 , 2003, The Journal of Immunology.

[65]  V. Holers,et al.  Role of complement in the development of autoimmunity. , 2002, Current directions in autoimmunity.

[66]  T. Kanzaki,et al.  Prediction of postpartum onset of rheumatoid arthritis , 1998, Annals of the rheumatic diseases.

[67]  B. Dijkmans,et al.  The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. , 2003, The Journal of rheumatology.

[68]  Y. Shoenfeld,et al.  Evaluation of the BioPlex™ 2200 ANA Screen: Analysis of 510 Healthy Subjects: Incidence of Natural/Predictive Autoantibodies , 2005, Annals of the New York Academy of Sciences.

[69]  R. H. Scofield,et al.  SS-A (Ro) Autoantibodies , 1996 .

[70]  Nicola Bizzaro,et al.  Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method , 2006, Clinical chemistry and laboratory medicine.

[71]  M. McClain,et al.  The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[72]  W. Maksymowych,et al.  The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. , 2006, The Journal of rheumatology.